Medical Imaging

Medical imaging is required to meet the needs of advanced diagnostics and the demands of emerging markets, presenting the sector with sizeable rewards for innovation.

Medical Imaging

TTP’s expertise in medical imaging and understanding of the market allows us to help our clients to turn innovative ideas into marketable products rapidly.


A critical part of diagnosing injuries and illnesses is the ability to see within the body. Pioneered by Roentgen’s work with X-rays, medical imaging encompasses a wide range of techniques to achieve this. Today, X-rays have advanced to allow both tracking of movement through fluoroscopy and the reconstruction of 3D volumes through computed tomography.

While imaging based on X-rays provides a powerful tool, there are reasonable concerns over the safety for both patients and clinicians exposed to ionising radiation and this has led to a push for lowering radiation dose. Advanced CT scanners now dynamically minimise the exposure required for a given image quality, and clinicians are increasingly looking to use alternatives to fluoroscopy, such as real-time MRI and ultrasound.

While these techniques use different technical means of creating the images, the factors driving their development are common: a desire to provide diagnostic power safely to as wide a patient population as possible. The push for improved diagnostic power has led to the development of new contrast mechanisms, such as ultrasound shearwave elastography, photoacoustics, and the use of hyperpolarised contrast agents in MRI.

The drive for imaging to reach new patients is evident in low-cost devices for emerging markets, such as hand-held ultrasound systems that work with a user’s mobile phone and ultra- low-field MRI scanners. Compact versions of CT and ultrasound systems are being developed for emergency medicine uses, together with telemedicine and machine learning capabilities to allow paramedics to perform rapid on-site diagnosis.

Explore More industries

Life Science

We work at the intersection of physics, engineering and the biological sciences, creating and developing new technology for the life science industry.

Drug Delivery

Pharmaceutical companies face substantial challenges, from constraints in health spending to weakening drug pipelines. Yet opportunities exist for those bold enough to adapt, ranging from connected devices that drive adherence to generic devices at cost points previously thought impossible.

Medical Devices

Disruptive change is rolling through the medical device industry as value-based healthcare and digitisation spread from niches to the mainstream. This is a challenging time, but it presents real opportunities for those ambitious companies prepared to reinvent themselves.

In-vitro Diagnostics

The diagnostic market is at a moment of change. New approaches, such as sequencing, are gaining traction; companion diagnostics are driving closer integration with therapy; continuous monitoring is enabling new diagnostic information; and market drivers are demanding low cost distribution of clinical quality data.


Human therapies are adapting to tackle increasingly complex immunological diseases and conditions. These therapies often rely on tightly controlled cell cultures in order to produce therapeutic drugs efficiently, such as monoclonal antibodies or culture of the patient’s own genetically-engineered cells, as part of an autologous cell therapy workflow.


Emerging biosensor technologies are enabling the measurement and analysis of valuable trace markers, leading to improved clinical outcomes by allowing the accurate observation of previously undetectable physiological signals in real time.

Smart Implants

Increasing numbers of people are suffering from chronic conditions. Through the creation of tiny, fully integrated real-time measurement systems, smart implants are bringing the benefits of laboratory-grade telemetry to their lives.

Digital Health

Healthcare consumers are no longer willing to accept a poor user experience, and the consumer world has set their expectations sky-high. We design products and health experiences encompassing both physical and digital products for the healthcare consumers of tomorrow.


Surgery is a fertile area for medical device innovation with remarkable developments occurring in minimally invasive and robotic assisted techniques. The future of the operating room relies on intraoperative technologies which improve clinical and economic values as measured by procedure outcome, workflow efficiency and patient safety.

Cell and Gene Therapy

Cell and Gene Therapies can cure the incurable. With more than a decade of experience, TTP works in partnership with companies to solve the challenges of these complex therapies. Together we will improve patient access and save lives.


Neurotechnology promises to revolutionise the treatment of a wide range of diseases. Improving outcomes for patients depends on bringing together an understanding of the pathology with the medical device hardware needed to physically interface with the nervous system.

Get in touch

We use cookies to improve your experience on our site. To find out more, read our updated privacy policy. More information.